Ads
related to: zoetis petcare rewards cytopoint
Search results
Results From The WOW.Com Content Network
Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [ 5 ] [ 4 ] [ 6 ] The company was a subsidiary of Pfizer , [ 7 ] the world's largest drug maker , but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.
Lokivetmab, trade name Cytopoint, is a monoclonal antibody used to treat atopic dermatitis in dogs. [1] It acts against interleukin 31 (IL-31), [ 2 ] which is a cytokine involved in causing itchiness (pruritus). [ 2 ]
Zoetis (NYSE: ZTS) Q3 2024 Earnings Call Nov 04, ... and Librela has already become the fourth largest product in U.S. pet care. This highlights the demand and long-term growth potential ...
Zoetis (NYSE: ZTS) Q2 2024 Earnings Call Aug 06, ... Simparica Trio, and Cytopoint. With our global footprint and world-class manufacturing facilities, we ensure consistent quality and on-time ...
Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up short in its fourth quarter. Zoetis' revenue rose 5% in the quarter to ...
Zoetis said in May that despite lower visits to vet clinics for wellness and diagnostic products, the company's growth was being driven by its medical treatments for chronic conditions in pets.